Skip to main content
AEON
NASDAQ Life Sciences

AEON Cuts Warrant Strike to $0.20, Expects ~$6.2M From Induced Exercises

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.28
Mkt Cap
$16.13M
52W Low
$0.177
52W High
$1.45
52W Position info
58% above low
Off High info
81% below high
Rel. Volume
Market data snapshot near publication time

AEON sits 58% above its 52-week low of $0.177.

Summary

AEON amended its July 2026 milestone warrants to cut the exercise price to $0.20 from $0.3221, with certain holders agreeing to exercise and roughly $6.2 million in gross proceeds expected ahead of the November 16, 2026 expiration; the potential aggregate gross proceeds from cash exercise of all milestone warrants are now approximately $24.4 million, down from $29.6 million, reflecting the reduced two-year warrant exercise price.

Updated with an SEC 424B3 filing · What changed

Updates

  1. · SEC 424B3 — AEON's 424B3 updates potential aggregate gross proceeds from cash exercise of all milestone warrants to approximately $24.4 million, down from $29.6 million, reflecting the reduced two-year warrant exercise price.


Key Events · Financing and Capital Events · AEON

  • New · · SEC 424B3

    All-Warrant Exercise Proceeds Now ~$24.4M

    Potential aggregate gross proceeds from cash exercise of all milestone warrants are now approximately $24.4 million, down from $29.6 million, reflecting the reduced two-year warrant exercise price.

  • Warrant Strike Cut to $0.20

    Holders of at least 67% of the two-year milestone warrants issued July 15, 2026 consented to reduce the exercise price from $0.3221 to $0.20 per share ($0.1999 per Pre-Funded Warrant).

  • ~$6.2M Gross Proceeds Expected

    Certain holders agreed to exercise at the reduced price, and AEON expects approximately $6.2 million in gross proceeds from those exercises.

  • All Warrants Repriced, Not Just Signers

    Under Section 5(l) of the warrants, the amendment binds all outstanding two-year warrants whether or not the holder executed it; share counts and expiration date are unchanged.

  • Warrants Expire November 16, 2026

    Accelerated expiration was triggered by the September 30, 2026 announcement of FDA Type 2b meeting minutes that did not preclude the 351(k) biosimilar pathway for ABP-450.


Analysis · AEON · Life Sciences

AEON is trading paper for cash. Holders of at least 67% of the July 15, 2026 two-year milestone warrants agreed to drop the strike from $0.3221 to $0.20, and some of them committed to exercise now, which should bring in roughly $6.2 million gross. For a company this size, that is real money, and it arrives before the warrants expire on November 16, 2026. The cost is dilution: exercises at $0.20 land below today's $0.2797 quote, and because the amendment binds all outstanding warrants under Section 5(l), every holder gets the lower strike, not just the ones who signed. The lower strike also trims the potential aggregate gross proceeds from cash exercise of all milestone warrants to approximately $24.4 million from $29.6 million. The September 30, 2026 FDA minutes that cleared the 351(k) biosimilar path for ABP-450 triggered the accelerated expiration, so this is the company converting a ticking warrant overhang into cash while it still can.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AEON was trading at $0.28 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.1M. The 52-week trading range was $0.18 to $1.45. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AEON - Latest Insights

AEON
Nov 16, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.141
Real-time Price: $0.1102 info
Change: -$0.0308 (-22%) info
Market Cap: $6.7M info
AEON
Nov 16, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.141
Real-time Price: $0.1102 info
Change: -$0.0308 (-22%) info
Market Cap: $6.7M info
AEON
Nov 10, 2026, 12:12 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.172
Real-time Price: $0.1102 info
Change: -$0.0618 (-36%) info
Market Cap: $6.7M info
AEON
Nov 03, 2026, 8:43 AM EST
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.2797
Real-time Price: $0.1102 info
Change: -$0.1695 (-61%) info
Market Cap: $6.7M info